© 2020 MJH Life Sciences™ and Cancer Network. All rights reserved.
Don Rauf | Authors
Articles
PET/CT, 3T MRI perform equally well in lung cancer staging
September 01, 2008
No clear winner has emerged in a head-to-head comparison of whole-body FDG-PET/CT and whole-body 3T MRI for non-small-cell lung (NSCLC) cancer staging. Unenhanced PET/CT proved better for detecting metastatic lymph nodes and soft-tissue involvement, while MR was more sensitive to the presence of brain and liver metastases.